For example, it has been demonstrated recently that defectiveATM or CHK2 signaling renders p53-deficient tumor cells hypersensitive to Cisplatin,whereas the same defects had the opposite effect in tumor cells harboring wtp53[36]. The gene discussed is CHEK2; the disease is neoplasm.